Karin Eastham

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
South San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jonathan Wygant as attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Karin Eastham

Form 4 holding Director

GERON CORP

Security class
Common Stock
Shares / value
109,047
Estimated value
$248,627
Report date
13 Jan 2023
Price
$2.28
Ownership
Direct
Form 4 holding Director

NEKTAR THERAPEUTICS

Security class
Common Stock
Shares / value
23,233
Estimated value
$11,384
Report date
16 Sep 2022
Price
$0.4900
Ownership
Direct
Form 4 holding Director

VERACYTE, INC.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
$0
Report date
05 Dec 2025
Price
$13.19
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Personalis, Inc.

Security class
Stock Option (right to buy)
Shares / value
37,500
Estimated value
Report date
12 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

NEKTAR THERAPEUTICS

Security class
Stock Option
Shares / value
20,400
Estimated value
Report date
16 Sep 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

GERON CORP

Security class
Stock Options (right to buy)
Shares / value
0
Estimated value
Report date
13 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Karin Eastham

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .